Fortrea Holdings Inc.
Search documents
Fortrea Announces Date for First Quarter 2025 Financial Results and Conference Call
Newsfilter· 2025-04-15 11:00
Company Announcement - Fortrea will release its first quarter 2025 financial results on May 12, 2025, before the market opens [1] - A conference call will be held at 9:00 am ET on the same day to review the financial results and conduct a Q&A session [1] Participation Details - Participants can register for the earnings call online at the Fortrea Investor Relations website and are advised to join at least 10 minutes early to avoid delays [2] - A replay of the conference call will be available shortly after the event on the Fortrea Investor Relations website [2] Company Overview - Fortrea is a leading global provider of clinical development solutions to the life sciences industry, partnering with biopharmaceutical, biotechnology, medical device, and diagnostic companies [3] - The company offers phase I-IV clinical trial management, clinical pharmacology, and consulting services, leveraging over 30 years of experience across more than 20 therapeutic areas [3] - Fortrea operates in about 100 countries, providing focused and agile solutions to its customers globally [3]
FORTREA ALERT: Bragar Eagel & Squire, P.C. is Investigating Fortrea Holdings Inc. on Behalf of Fortrea Stockholders and Encourages Investors to Contact the Firm
Globenewswire· 2025-03-19 01:00
Core Insights - Fortrea Holdings Inc. is under investigation for potential violations of federal securities laws and unlawful business practices [1] - The company reported disappointing financial results for Q4 and full year 2024, indicating that pre-spin projects are underperforming and negatively impacting future revenue and profitability [2] - Following the financial announcement, Fortrea's stock price experienced a significant decline of 25.05%, closing at $10.38 per share [2] Financial Performance - Fortrea disclosed that projects from before its spin-off from LabCorp are "late in their life cycle" and are expected to generate less revenue and profitability in 2025 [2] - The company indicated that the mix of older versus newer projects will continue to adversely affect its financial performance throughout 2025 [2] Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of Fortrea stockholders who may have suffered losses [1][3] - The law firm is reaching out to long-term stockholders and those with information regarding the situation [3]